Saatja: <
[email protected]>
Saadetud: 24.03.2021 09:15
Adressaat: SM Info <
[email protected]>; Ministry of Health of the Republic of
Lithuania <
[email protected]>
Teema: 16.03.2021 Nr. 01-19.1/1494 "Par E.Gulbja laboratorijas testu
jauno pieeju"
LR Veselîbas ministrijaTâlr.: 67876000E-pasts:
[email protected]âjaslapa:
www.vm.gov.lv
Ðî vçstule ir paredzçta tikai personai vai personu grupai, kurai tâ ir
adresçta. Ðî e-pasta vçstule ir konfidenciâla, un var saturçt juridiski
aizsargâtu informâciju. Ja neesat ðîs vçstules paredzçtais adresâts,
paziòojam, ka vçstuli esat saòçmis kïûdas rezultâtâ, un pilnîga vai
daïçja iepazîðanâs ar tâs saturu, vçstules izmantoðana vai tâlâka
izplatîðana jebkâdâ veidâ ir stingri aizliegta. Ja esat saòçmis ðo
vçstuli kïûdas dçï, lûdzu sazinieties ar sûtîtâju, nosûtot atbildes e-
pasta vçstuli, pçc tam nekavçjoties vçstuli izdzçsiet (ieskaitot visus
pielikumus). This e-mail is intended only for the person or group of
people to whom it is addressed. This message is confidential and may
contain legally privileged information. If you an erot the intended
recine rt, you are hereby notified that you have received this message in
error and that reading it, copying it, or in any way disclosing its
content to any other person, is strictly unauthorized. If you have
received this message in error, please inform the sender by replying to
this e-mail and then immediately delete this e-mail (including any
attachments).
E.Gulbja Laboratorija
Reģ. Nr. 42803008077
Brīvības gatve 366, Rīgā, LV-1006
Tālr. +371 67545052, fakss +371 67543867
E-pasts:
[email protected]
Swedbanka, kods HABALV22, konta Nr. LV14HABA0001408038877
Sample requirements for SARS-CoV-2 mutation testing by RT-PCR
E. Gulbis Laboratory has developed a test which is currently being used routinely in Latvia for
detection of N501Y mutation and further detection of the B.1.1.7 SARS-CoV-2 virus variants.
The test detects E gene, RdRP gene and N501Y in a multiplex reaction, all N501Y “positive”
samples are further tested if it is the B.1.1.7 variant.
If N501Y is detected but B.1.1.7 is NOT confirmed it is recommended to perform a further viral
genome sequencing.
Turnaround time for the test is 24 hours.
Sample requirements:
• Nasopharyngeal and oropharyngeal swab in at least 300ul of transport medium (UTM or
VTM)
• Pozitive result where Ct value is less than or equal to 30
Any technical or additional details can be discussed via e-mail or by phone.
Prepared by:
Mikus Gavars
+37129237678
[email protected]